bw 373u86 has been researched along with n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine in 1 studies
| Studies (bw 373u86) | Trials (bw 373u86) | Recent Studies (post-2010) (bw 373u86) | Studies (n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine) | Trials (n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine) | Recent Studies (post-2010) (n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine) |
|---|---|---|---|---|---|
| 80 | 0 | 4 | 87 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, ER; Gross, GJ; Hsu, AK | 1 |
1 other study(ies) available for bw 373u86 and n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine
| Article | Year |
|---|---|
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
Topics: Analgesics, Opioid; Androstadienes; Animals; Benzamides; Benzopyrans; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanidines; Heart Rate; Imidazoles; Indoles; Ion Channel Gating; Male; Maleimides; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Sarcolemma; Signal Transduction; Time Factors; Wortmannin | 2007 |